| Synendos Therapeutics AG. (11/12/20). "Press Release: Synendos Therapeutics Raises CHF 20 Million in Series A Financing". Basel. |
2020-11-12 |
| Bayer AG. (11/12/20). "Press Release: Metagenomi Closes USD 65 Million Series A Financing Led by Leaps by Bayer and Humboldt Fund". Emeryville, CA & Leverkusen. |
2020-11-12 |
| Beckman Coulter Life Sciences. (11/12/20). "Press Release: Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs". Indianapolis, IN. |
2020-11-12 |
| Medigene AG. (11/12/20). "Press Release: Medigene Provides Q3 2020 Update". Planegg-Martinsried. |
2020-11-12 |
| MorphoSys AG. (11/11/20). "Press Release: MorphoSys and Cherry Biolabs Announce Licensing of Hemibody Technology". Planegg & Würzburg. |
2020-11-11 |
| MorphoSys AG. (11/11/20). "Press Release: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab". Monrovia, CA, Planegg & Wilmington, DE. |
2020-11-11 |
| BioNTech SE. (11/11/20). "Press Release: Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19". New York, NY & Mainz. |
2020-11-11 |
| Valneva S.E.. (11/10/20). "Press Release: Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potential US IPO". Saint-Herblain. |
2020-11-10 |
| Cevec Pharmaceuticals GmbH. (11/10/20). "Press Release: Cevec Signs Agreement with Roche for the Use of Cevec’s Elevecta Technology in Gene Therapy". Cologne. |
2020-11-10 |
| Catalym GmbH. (11/10/20). "Press Release: Catalym Raises EUR50 Million to Advance GDF-15 Antibody into Clinical Trials for Checkpoint-inhibitor Refractory Patients". Munich. |
2020-11-10 |
| Merck KGaA. (11/9/20). "Press Release: Merck Announces Out-licensing Agreement for Investigational Atacicept with Vera Therapeutics [Not intended for UK and US based media]". Darmstadt. |
2020-11-09 |
| Apeiron Biologics AG. (11/9/20). "Press Release: Apeiron Biologics AG and Domainex Ltd Announce the Expansion of Their Partnership to Progress Targeted Cancer Immune Therapy Drug Discovery". Vienna & Saffron Waldon. |
2020-11-09 |
| BioNTech SE. (11/9/20). "Press Release: Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study". New York, NY & Mainz. |
2020-11-09 |
| Bayer AG. (11/9/20). "Press Release: Bayer Submits Marketing Authorization Applications for Finerenone in the U.S. and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes". Berlin. |
2020-11-09 |
| Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY. |
2020-11-09 |
| Kurma Partners. (11/9/20). "Press Release: Kurma Partners Strengthens Its Teams and Promotes Its Talents". Paris. |
2020-11-09 |
| Singleron Biotechnologies. (11/9/20). "Press Release: Singleron Completes Series A1 Financing, Raising more than $10M". |
2020-11-09 |
| [iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen. |
2020-11-08 |
| PledPharma AB. (11/6/20). "Press Release: Henrik Krook Appointed VP Commercial Operations at PledPharma". Stockholm. |
2020-11-06 |
| Memo Therapeutics AG. (11/5/20). "Press Release: Memo Therapeutics AG Raises CHF 14 Million in a Series B Financing Round". Schlieren. |
2020-11-05 |
| Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam. |
2020-11-02 |
| Corlieve Therapeutics S.A.S.. (11/2/20). "Press Release: Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions". Paris. |
2020-11-02 |
| EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels. |
2020-11-02 |
| Vedere Bio, Inc.. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company". Cambridge, MA. |
2020-10-29 |
| Novartis AG. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, Adding Novel Optogenetic Gene Therapy Technology for Treating Blindness". Basel. |
2020-10-29 |
| CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA. |
2020-10-28 |
| EBD Group. (10/28/20). "Press Release: BIO-Europe Digital Startup Slam Winner 2020 – KyNexis Medicine Development". Munich. |
2020-10-28 |
| Galecto, Inc.. (10/28/20). "Press Release: Galecto Announces Pricing of Initial Public Offering". Boston, MA & Copenhagen. |
2020-10-28 |
| Trenzyme GmbH. (10/28/20). "Press Release: Successful Anniversary Year for Trenzyme – also with Corona.
Constance-based Biotechnology Company Trenzyme Celebrates Its 20th Anniversary". Konstanz. |
2020-10-28 |
| OpGen, Inc.. (10/28/20). "Press Release: OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators". Gaithersburg, MD & Holzgerlingen. |
2020-10-28 |
| Molecular Partners AG. (10/28/20). "Press Release: Molecular Partners Announces Collaboration with Novartis to Develop Two DARPin Therapies Designed for Potential Use against COVID-19". Zürich-Schlieren. |
2020-10-28 |
| Sidekick Health. (10/28/20). "Press Release: Sidekick Raises $20M in Series A Funding Round Led by Wellington and Asabys". Barcelona, Munic & Reykjavik. |
2020-10-28 |
| Bayer AG. (10/27/20). "Press Release: Bayer Appoints Dr. Christian Rommel as New Head of Pharmaceuticals Research and Development". Berlin. |
2020-10-27 |
| TVM Capital Life Science. (10/27/20). "Press Release: TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, Largest Fund in the Firm’s History ". Munich & Montreal. |
2020-10-27 |
| Eternygen GmbH. (10/26/20). "Press Release: Eternygen Announces the First Closing of Its Series A2 Funding Round". Berlin. |
2020-10-26 |
| NBE Therapeutics AG. (10/26/20). "Press Release: NBE-Therapeutics Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate for Patients with Solid Tumors". Basel. |
2020-10-26 |
| Bayer AG. (10/26/20). "Press Release: Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy". Berlin. |
2020-10-26 |
| MLM Medical Labs GmbH. (10/26/20). "Press Release: MLM Medical Labs Continues International Growth with Addition of MD Biosciences in the United States". |
2020-10-26 |
| Life Science Nord Management GmbH. (10/23/20). "Press Release: Industrial Health Economy on a Steady Course in Northern Germany". Hamburg. |
2020-10-23 |
| Araris Biotech AG. (10/22/20). "Press Release: Araris Biotech Completes CHF 15.2 Million Seed Financing Round". Zürich. |
2020-10-22 |
| Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA. |
2020-10-22 |
| ProBioGen AG. (10/22/20). "Press Release: Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services". Berlin. |
2020-10-22 |
| Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. |
2020-10-20 |
| Proteintech Group, Inc.. (10/20/20). "Press Release: Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools". Chicago, IL & Munich. |
2020-10-20 |
| Siemens Healthineers AG. (10/20/20). "Press Release: Siemens Healthineers Invests in the Growth Market India and Drives Digitalization of Healthcare by Setting Up an Innovation Hub in Bengaluru". Erlangen & Bengaluru. |
2020-10-20 |
| Atriva Therapeutics GmbH. (10/20/20). "Press Release: Germany – EIB Backs Atriva Therapeutics with €24 Million for the Development of a Potential COVID-19 Treatment". Germany. |
2020-10-20 |
| Selexis S.A.. (10/20/20). "Press Release: JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland". Sunnyvale, CA. |
2020-10-20 |
| Vifor Pharma AG. (10/20/20). "Press Release: Vifor Pharma and Cara Therapeutics Sign US License Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus". St. Gallen & Stamford, CT. |
2020-10-20 |
| Immunic, Inc.. (10/20/20). "Press Release: EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy". Luxembourg, Gräfeling & New York, NY. |
2020-10-20 |
| Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing". Hamburg. |
2020-10-19 |
| Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer". Hamburg. |
2020-10-19 |
| Cevec Pharmaceuticals GmbH. (10/19/20). "Press Release: Cevec and Rznomics Sign License Agreement for the Use of CAP Technology in Manufacturing of Adenoviral Vectors". |
2020-10-19 |
| Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried. |
2020-10-19 |
| Selexis S.A.. (10/16/20). "Press Release: Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer". Geneva. |
2020-10-16 |
| SmartDyeLivery GmbH. (10/15/20). "Press Release: Successful Multi-million Financing Round for SmartDyeLivery GmbH". Erfurt & Jena. |
2020-10-15 |
| Bayer AG. (10/15/20). "Press Release: Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra". Leverkusen & Branford, CT. |
2020-10-15 |
| VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel. |
2020-10-15 |
| Touchlight Genetics Ltd.. (10/15/20). "Press Release: Touchlight Appoints Karen Fallen as CEO of Touchlight DNA Services". Hampton. |
2020-10-15 |
| RayzeBio, Inc.. (10/14/20). "Press Release: RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics". San Diego, CA. |
2020-10-14 |
| Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil. |
2020-10-14 |
| ERS Genomics Ltd.. (10/14/20). "Press Release: ERS Genomics Announces agreement with Fasmac to Commercialize CRISPR/Cas9 Research Reagents in Japan". Dublin & Kanagawa. |
2020-10-14 |
| Siemens Healthineers AG. (10/14/20). "Press Release: Siemens Healthineers Launches Rapid Antigen Test for the Detection of SARS-CoV-2 [Not for publication in the USA]
". Erlangen. |
2020-10-14 |
| Rentschler Biopharma SE. (10/14/20). "Press Release: Rentschler Biopharma and ATUM Announce Leap-In Transposase Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins". Laupheim, Milford, MA & Newark, CA. |
2020-10-14 |
| Iksuda Therapeutics Ltd.. (10/13/20). "Press Release: Iksuda Therapeutics Enters License Agreement with University of Goettingen to Develop a New Generation of Antibody Drug Conjugates". Newcastle. |
2020-10-13 |
| Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. |
2020-10-13 |
| Rappta Therapeutics Oy. (10/13/20). "Press Release: Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A Drugs". Helsinki. |
2020-10-13 |
| Qiagen N.V.. (10/13/20). "Press Release: Qiagen Reports Strong Preliminary Results for Third Quarter of 2020". Venlo. |
2020-10-13 |
| MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg. |
2020-10-13 |
| MorphoSys AG. (10/13/20). "Press Release: Ad hoc – MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds". Planegg. |
2020-10-13 |
| Evotec SE. (10/13/20). "Press Release: Mubdala Investment Company and Novo Holdings A/S Invest €250m in Evotec SE". Hamburg. |
2020-10-13 |
| Chord Therapeutics S.A.. (10/13/20). "Press Release: Chord Therapeutics Launches with USD 16 Million Series A Financing from Omega Funds". |
2020-10-13 |
| Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin. |
2020-10-12 |
| Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt. |
2020-10-12 |
| BioNTech SE. (10/9/20). "Press Release: Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2". Kirkland, QC & Mainz. |
2020-10-09 |
| Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. |
2020-10-09 |
| Relief Therapeutics Holding AG. (10/8/20). "Press Release: Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer". Geneva. |
2020-10-08 |
| Merck KGaA. (10/8/20). "Press Release: Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant". Darmstadt. |
2020-10-08 |
| Evotec SE. (10/8/20). "Press Release: Evotec Achieves Milestone in Neurodegeneration Collaboration with Bristol Myers Squibb". Hamburg. |
2020-10-08 |
| Sensei Biotherapeutics, Inc.. (10/7/20). "Press Release: Sensei Biotherapeutics Announces $28.5 Million Financing To Advance Clinical Pipeline and Immunophage Platform Targeting Multiple Cancers". Boston, MA & Gaithersburg, MD. |
2020-10-07 |
| Rentschler Biopharma SE. (10/7/20). "Press Release: Joining Forces against SARS-CoV-2. Rentschler Biopharma Contributes to Manufacturing of COVID-19 mRNA Vaccine". Laupheim & Milford, MA. |
2020-10-07 |
| Merck KGaA. (10/6/20). "Press Release: Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis [Not intended for UK and US based media]". Darmstadt. |
2020-10-06 |
| Santhera Pharmaceuticals Holding AG. (10/6/20). "Press Release: Santhera to Discontinue Phase 3 SIDEROS Study and Development of Puldysa in Duchenne Muscular Dystrophy (DMD) and Focus on Vamorolone". Pratteln. |
2020-10-06 |
| Federation Bio. (10/6/20). "Press Release: Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies". South San Francisco, CA. |
2020-10-06 |
| BioNTech SE. (10/6/20). "Press Release: BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2". New York, NY & Mainz. |
2020-10-06 |
| Sirion Biotech GmbH. (10/6/20). "Press Release: Mustang Bio Licenses LentiBOOST Technology from Sirion Biotech for the Development of MB-207 Lentiviral Gene Therapy". Worcester, MA & Martinsried. |
2020-10-06 |
| High-Tech Gründerfonds Management GmbH. (10/5/20). "Press Release: btov Partners, HV Holtzbrinck Ventures and HTGF Invest in Real World Evidence and Patient-reported Outcomes. 5 Million Euros for Heartbeat Medical". |
2020-10-05 |
| Qiagen N.V.. (10/5/20). "Press Release: Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit that Simplifies and Accelerates PCR Analysis for Research Applications". Hilden & Germantown, MD. |
2020-10-05 |
| Sartorius AG. (10/2/20). "Press Release: Purification Specialist BIA Separations to Become Part of Sartorius". Göttingen. |
2020-10-02 |
| Centre for Research on Multinational Corporations (SOMO). (10/2/20). "Press Release: New Research Reveals Large-scale Tax Avoidance by Coronavirus Test Manufacturer Qiagen". |
2020-10-02 |
| Kaleido Biosciences, Inc.. (10/1/20). "Press Release: Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer". Lexington, MA. |
2020-10-01 |
| High-Tech Gründerfonds Management GmbH. (10/1/20). "Press Release: Neuromodulation Pioneer Wise Closes EUR 15M Series C Financing Round to Launch Second Product, SCS EXPERT, for Chronic Pain". |
2020-10-01 |
| Vaccibody AS. (10/1/20). "Press Release: Vaccibody Enters into Worldwide License and Collaboration Agreement with Genentech, a Member of the Roche Group, to Develop Individualized Neoantigen Cancer Vaccines". Oslo. |
2020-10-01 |
| Sophia Genetics S.A.. (10/1/20). "Press Release: Sophia Genetics Raises $110 Million in Oversubscribed New Funding Round". Lausanne & Boston, MA. |
2020-10-01 |
| ECBF Management GmbH. (10/1/20). "Press Release: New European Circular Bioeconomy Fund Is Ready to Invest in Europe's Transition to a more Sustainable Economy". Bonn. |
2020-10-01 |
| MorphoSys AG. (9/30/20). "Press Release: MorphoSys Announces Departure of Jens Holstein, CFO, by Year End 2020". Planegg. |
2020-09-30 |
| Bruker Corporation. (9/30/20). "Press Release: Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies". Billerica, MA. |
2020-09-30 |
| Numab Therapeutics AG. (9/30/20). "Press Release: Numab Therapeutics Appoints Daniel Vasella as New Chairman of the Board". Wädenswil (Zurich). |
2020-09-30 |
| NanoSyrinx Ltd.. (9/30/20). "Press Release: Synthetic Biology Start Up NanoSyrinx Secures Capital to Develop Its Fully Customisable Platform for Intra-cellular Engineering". Coventry. |
2020-09-30 |
| Kurma Partners. (9/29/20). "Press Release: Kurma Partners Announces the First Closing of Kurma Diagnostics 2 (KDx2) Fund at €50 Million". Paris. |
2020-09-29 |
| Merck KGaA. (9/29/20). "Press Release: Press Release as a Result of the Ad-hoc Announcement of September 29, 2020". Darmstadt. |
2020-09-29 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220406-650-100-promote-brand-to-decision-makers.jpg)
1 2 3 ... 10 11 12 ... 50 51 52 
Date![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
